Indefinite Delivery Contract SPE2DX15D1050

This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued up to $4,999,999.00, covers the delivery of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen, through its parent company Cencora, Inc., has extensive experience in the federal pharmaceutical distribution market, holding significant IDCs with the DLA and Department of Justice. The task orders under this IDC demonstrate the delivery of critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas such as cardiovascular health, diabetes management, mental health, and infectious disease prevention. The contract has an ultimate completion date of December 31, 2025 and serves as a primary vehicle for the DLA to efficiently procure essential pharmaceutical and medical supplies for military treatment facilities, veterans' healthcare programs, and other federal medical institutions.